Skip to main content

Table 1 Characteristics of HSCT patients

From: Patterns of central nervous system complications of post-hematopoietic stem cell transplant in pediatric oncology patients: a single institute experience

  Total cases AutoSCT AlloSCT
Age (in years)
Mean 8.2 7.6 9.1
Median 6.5 6 8.3
Standard deviation 5.2 5.1 5.2
Minimum 0.9 1 0.9
Maximum 25 25 19.3
Sex
Female 190 114 76
Male 335 197 138
Initial diagnosis No (%) No (%) No (%)
Neuroblastoma (NB) 210 (40%) 208 (66.9%) 2 (0.9%)
  CR 148 1
  Othersa 60 1
Non-Hodgkin lymphoma (NHL) 21 (4%) 11 (3.5%) 10 (4.7%)
  1st CR 2 1
  2nd CR 9 9
Acute myeloid leukemia (AML) 76 (14.5%) 2 (0.6%) 74 (34.6%)
  1st CR 1 43
  2nd CR 1 31
Acute lymphoblastic leukemia (ALL) 44 (8.2%) 1 (0.32%) 43 (20.1%)
  1st CR   0 26
  2nd CR 1 17
Myelodysplastic/myeloproliferative syndrome 80 (15.2%) 0 (0%) 80 (37.3%)
Hemophagocytic lymphohistocytosis (HLH) 5 (1%) 0 (0%) 5 (2.3%)
Hodgkin lymphoma (HL) 77 (14.7%) 77 (24.8%) 0 (0%)
  Refractory 63
  Relapsing 14
Relapsing Wilms’s 2 (0.4%) 2 (0.6%) 0 (0%)
  Extraocular retinoblastoma (RB) 10 (1.9%) 10 (3.2%) 0 (0%)
Total 525 (100%) 311 (100%) 214 (100%)
  1. aOthers contain very good PR and PR neuroblastoma patients
  2. CR Complete response, PR Partial response